Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

64.7K
Overview
64.7K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

3.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

6.9K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
6.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HIV-specific and resistant CAR T cells promote control of HIV replication in people with HIV.

Research square·2026
Same author

NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Cell-derived Nanoparticles Provide a Robust Platform to Manufacture Therapeutic T cells.

Research square·2026
Same author

Phase 1 study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Performance of Treatment Response Assessment at Day 7 by Baseline Acute Graft-versus-Host Disease Severity.

Transplantation and cellular therapy·2025
Same author

Enhanced CAR T-Cell Therapy for Relapsed Lymphoma. Reply.

The New England journal of medicine·2025

Related Experiment Video

Updated: May 1, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

17.2K

Host-reactive CD8+ memory stem cells in graft-versus-host disease.

Yi Zhang1, Gerard Joe, Elizabeth Hexner

  • 1Department of Medicine, University of Pennsylvania School of Medicine, Room 510, Maloney, 3600 Spruce Street, Philadelphia, Pennsylvania 19104, USA.

Nature Medicine
|November 17, 2005
PubMed
Summary

Researchers discovered a new type of CD8(+) T cell that sustains graft-versus-host disease (GVHD) by self-renewing and generating other T cell types. These "memory stem cells" could be key targets for managing chronic immune reactions.

More Related Videos

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

18.4K
Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

7.3K

Related Experiment Videos

Last Updated: May 1, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

17.2K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

18.4K
Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

7.3K

Area of Science:

  • Immunology
  • Cell Biology
  • Transplantation Science

Background:

  • Graft-versus-host disease (GVHD) is a significant complication of allogeneic stem cell transplantation.
  • The mechanisms sustaining chronic immune responses like GVHD over time remain poorly understood.

Purpose of the Study:

  • To identify the cellular mechanisms responsible for maintaining T-cell responses in GVHD.
  • To characterize novel T-cell subsets involved in the long-term pathogenesis of GVHD.

Main Methods:

  • Utilized mouse models of human GVHD.
  • Phenotypic characterization of T-cell subsets using flow cytometry (CD44, CD62L, Sca-1, CD122).
  • Functional assays including T-cell subset generation and GVHD induction upon transfer.

Main Results:

  • Identified a novel subset of postmitotic CD8(+) T cells (CD44(lo)CD62L(hi)) that self-renew and generate diverse allogeneic T-cell populations.
  • These cells express Sca-1, CD122, and Bcl-2, persist throughout GVHD, and induce GVHD in secondary recipients.
  • Generation of these cells requires alloantigens, dendritic cells, and interleukin-15.

Conclusions:

  • These unique CD8(+) T cells function as memory stem cells, capable of self-renewal and multipotency.
  • These memory stem cells are critical for sustaining GVHD and may represent important therapeutic targets for chronic immune reactions.